Holen Sie sich die Stockscreener-App
3.415
0.58%
-0.025
Schlusskurs vom Vortag:
$3.44
Offen:
$3.43
24-Stunden-Volumen:
647.22K
Relative Volume:
0.14
Marktkapitalisierung:
$336.65M
Einnahmen:
$775.09M
Nettoeinkommen (Verlust:
$-58.68M
KGV:
-25.75
EPS:
-0.1326
Netto-Cashflow:
$64.06M
1W Leistung:
-13.42%
1M Leistung:
-19.15%
6M Leistung:
-26.13%
1J Leistung:
-44.12%
1-Tages-Spanne:
$3.3912
$3.445
1-Wochen-Bereich:
$3.3912
$3.99
52-Wochen-Spanne:
$3.305
$6.345
Goodrx Holdings Inc Stock (GDRX) Company Profile
Firmenname
Goodrx Holdings Inc
Sektor
Branche
Telefon
(855) 268-2822
Adresse
2701 OLYMPIC BOULEVARD, SANTA MONICA
Vergleichen Sie GDRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
3.415 | 1.20B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
288.62 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.74 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.62 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.30 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.22 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-08-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-10 | Hochstufung | DA Davidson | Neutral → Buy |
| 2023-07-31 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Eingeleitet | Citigroup | Buy |
| 2022-11-04 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-12 | Eingeleitet | DA Davidson | Neutral |
| 2022-06-10 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-06 | Fortgesetzt | BofA Securities | Buy |
| 2022-06-01 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-03-15 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Bestätigt | Barclays | Overweight |
| 2022-03-01 | Bestätigt | BofA Securities | Neutral |
| 2022-03-01 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-03-01 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Bestätigt | Evercore ISI | Outperform |
| 2022-03-01 | Bestätigt | Goldman | Buy |
| 2022-03-01 | Bestätigt | JP Morgan | Underweight |
| 2022-03-01 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-03-01 | Bestätigt | SVB Leerink | Outperform |
| 2022-01-07 | Eingeleitet | Goldman | Buy |
| 2021-12-21 | Eingeleitet | Stephens | Overweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-08-31 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-06 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-01-25 | Eingeleitet | Guggenheim | Buy |
| 2020-11-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Eingeleitet | Barclays | Equal Weight |
| 2020-10-19 | Eingeleitet | BofA Securities | Neutral |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-10-19 | Eingeleitet | Cowen | Outperform |
| 2020-10-19 | Eingeleitet | Credit Suisse | Outperform |
| 2020-10-19 | Eingeleitet | Deutsche Bank | Hold |
| 2020-10-19 | Eingeleitet | Goldman | Neutral |
| 2020-10-19 | Eingeleitet | JP Morgan | Neutral |
| 2020-10-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-10-19 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Eingeleitet | SVB Leerink | Outperform |
| 2020-10-19 | Eingeleitet | UBS | Buy |
Alle ansehen
Goodrx Holdings Inc Aktie (GDRX) Neueste Nachrichten
Custom watchlist performance reports with GoodRx Holdings Inc.Quarterly Profit Summary & Fast Momentum Entry Tips - newser.com
How analysts rate GoodRx Holdings Inc. stock todayQuarterly Market Review & Verified Technical Trade Signals - newser.com
Institutional scanner results for GoodRx Holdings Inc.July 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Real time social sentiment graph for GoodRx Holdings Inc.Long Setup & Real-Time Buy Signal Notifications - newser.com
Detecting price anomalies in GoodRx Holdings Inc. with AIDividend Hike & Growth Oriented Trading Recommendations - newser.com
Is GoodRx Holdings Inc. meeting your algorithmic filter criteriaTrade Signal Summary & Safe Entry Trade Signal Reports - newser.com
Does GoodRx Holdings Inc. fit your quant trading model2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Risk adjusted return profile for GoodRx Holdings Inc. analyzedTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Smart tools for monitoring GoodRx Holdings Inc.’s price actionJuly 2025 Intraday Action & Short-Term Trading Alerts - newser.com
Measuring GoodRx Holdings Inc.’s beta against major indicesDollar Strength & AI Based Buy and Sell Signals - newser.com
Reversal indicators forming on GoodRx Holdings Inc. stockTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com
Real time breakdown of GoodRx Holdings Inc. stock performanceForecast Cut & Growth-Oriented Investment Plans - newser.com
Does GoodRx Holdings Inc. qualify in momentum factor screeningEarnings Recap Report & Daily Growth Stock Tips - newser.com
Is GoodRx Holdings Inc. still worth holding after the dipWeekly Stock Summary & Expert Approved Momentum Trade Ideas - newser.com
How GoodRx Holdings Inc. stock performs after earningsMarket Movement Recap & High Accuracy Swing Entry Alerts - newser.com
Quantitative breakdown of GoodRx Holdings Inc. recent moveJuly 2025 Sentiment & Entry Point Confirmation Alerts - newser.com
How sentiment analysis helps forecast GoodRx Holdings Inc.Watch List & Technical Buy Zone Confirmation - newser.com
Finanzdaten der Goodrx Holdings Inc-Aktie (GDRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.56%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):